GlassScriptPhysician profile
Blake Okeefe Stone
NPI 1447956305
$1,023.70
in general payments reported to CMS, 2019-2025
6 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $196 · 2024: $367 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Education: $67.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.14 |
| Education | $67.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $454.09 | 2024-2025 | Airsupra, Breztri, Tezspire |
| Mylan Specialty L.P. | $289.02 | 2023-2024 | Yupelri |
| Viatris Specialty LLC | $194.17 | 2025 | Yupelri |
| Glaxosmithkline, LLC. | $48.49 | 2025 | Trelegy Ellipta, Nucala |
| Eagle Pharmaceuticals, INC. | $20.78 | 2023 | |
| Inspire Medical Systems, INC. | $17.15 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.